|
March 10, 2008 Calistoga Pharmaceuticals initiates its First Clinical Study of Novel Oral PI3K Delta Compound, CAL-101...read more>
February 14th, 2008 Reuters – New target promises better asthma and allergy drugs...read more>
February 13th, 2008 Calistoga Pharmaceuticals Appoints R. Lee Douglas to BOD ...read more>
January 3rd, 2008 Calistoga Pharmaceuticals announces completion of its Series A Financing - Investors increased funding by 25% to total $26.2 Million...read more>
|